Technology

Voronoi, Inc.’s Stock Plummets, Dragging Down Collateral Value… CEO Faces Burden of Refinancing 40 Billion Won Mortgage

KIM SUNG-JIN
2026-11-23 07:21:02
[Edaily Reporter KIM SUNG-JIN ] Voronoi, Inc.(310210) With the stock price having fallen by more than 70% in about eight months, CEO Kim Hyun-tae’s 40 billion won stock-backed loan is set to mature this month and next month, according to public disclosures. Although the collateral ratio, calculated based on the current stock price, remains above the required threshold, the reduced collateral value means that loan limits and interest rates could become a burden during the process of extending the maturity or refinancing. The actual financial burden is expected to depend on whether additional collateral is provided and the outcome of negotiations with financial institutions.

Down
70% from March’s peak… CEO’s total stock-backed loans amount to 40 billion won
As of the close on the 19th, Voronoi, Inc.’s stock price stood at 108,500 won. Compared to the all-time high of 375,500 won reached in March of this year, the stock price has fallen by 71.1% over the past eight months. As the market value of the shares provided as collateral has decreased due to the stock price decline, market attention is turning to the loan agreements of the largest shareholder.

According to the major shareholder stake report disclosed on August 31, CEO Kim has entered into stock-backed loan agreements totaling 45 billion won: 20 billion won with Meritz Securities, 20 billion won with KIWOOM Securities, and 5 billion won with Yuanta Securities Korea.

Specifically, he borrowed 20 billion won from Meritz Securities, pledging 838,927 shares as collateral, with an interest rate set at 13.0%. The contract period runs from August 26 of last year to November 19 of this year. The company agreed to borrow 20 billion won from KIWOOM Securities at an interest rate of 8.5% until December 4 of this year, and received a 5 billion won loan from Yuanta Securities Korea at an interest rate of 8.0%.

The problem is that stock prices are falling just as the stock-backed loans—20 billion won each from Meritz Securities and KIWOOM Securities, for a total of 40 billion won—are nearing maturity. Applying the closing price of 108,500 won on the 19th to the number of shares listed as collateral in the disclosure, the collateralization ratios are estimated at 455.1% for Meritz Securities and 382.0% for KIWOOM Securities. Although both exceed the 300% maintenance margin requirement, if the stock price continues to fall, the companies may be required to provide additional collateral or make partial repayments during the maturity extension or refinancing process.

Yuanta Securities Korea’s 5 billion won loan reportedly matured on September 14, according to public disclosures. It remains unclear whether the loan was repaid or extended after that date. Assuming the original loan principal and 150,000 shares of collateral remain unchanged, the collateral ratio is estimated at 307.2% based on the closing price on the 3rd.

The collateral ratio is an indicator of how much the value of the collateral assets is relative to the loan amount. A collateral maintenance ratio of 300% means that the value of the collateral must be maintained at three times the loan amount. When the principal amount and the number of shares used as collateral remain unchanged, the collateral ratio decreases as the stock price falls; if the stock price continues to decline, the borrower may be required to provide additional shares as collateral or repay a portion of the loan.

Meeting the Collateral Ratio Does Not Guarantee an Extension… Refinancing Conditions Are a Variable
Apart from the maintenance margin ratio, pressure
to refinance
is expected to increase as loan maturities approach. A decline in stock prices could be particularly burdensome during this process. This is because as the appraised value of the collateralized shares decreases, the amount of funds that can be raised using the same number of shares also decreases. If the new loan amount falls short of the existing loan balance, the borrower may have to provide additional shares as collateral or repay the difference using their own funds.

Interest rates are another variable. If the volatility of the collateralized stocks is high and the risk of loan recovery is assessed as high, interest rates are likely to rise accordingly. Furthermore, the trend of steadily rising interest rates since last year is also an unfavorable factor. The Bank of Korea’s benchmark interest rate currently stands at 3.00%, up 0.5 percentage points (p) from 2.50% in May of last year.

An industry insider in the investment banking sector stated, “While loan terms vary widely depending on how mortgage loan conditions are set, given the recent deterioration in market conditions and rising interest rates, the burden of refinancing is expected to increase.”

The interest rates on the loans from Meritz Securities and KIWOOM Securities disclosed by CEO Kim are 13% and 8.5% per annum, respectively. Based on a simple calculation assuming a principal of 20 billion won each maintained at the same rate for one year, the interest burden would amount to 2.6 billion won and 1.7 billion won, respectively, for a total of 4.3 billion won.

Past Disputes Over Maturity Extensions
Another reason why attention is focused on these loans is that CEO Kim has a history
of
legal disputes with securities firms over the extension of stock-backed loan maturities. In August 2023, CEO Kim borrowed 25 billion won from Korea Investment & Securities by pledging 850,000 shares as collateral, but just three months later, in November of the same year, he was informed that the maturity could not be extended and was required to repay the loan.

CEO Kim’s side filed a lawsuit against Korea Investment & Securities, disputing the legitimacy of the maturity date and the repayment demand. At the time, the 850,000 shares CEO Kim had pledged as collateral were subject to a three-year lock-up period following Voronoi, Inc.’s initial public offering in June 2022.

A source in the pharmaceutical and biotech industry stated, “With liquidity recently drying up in the market, stock prices of many biotech companies are trending downward,” adding, “Consequently, there is an increasing number of cases where executives who took out secured loans using stocks are facing repayment pressure.”

Economy

Corporation

IT·Science

Economy

"Chinese Stablecoin Payments Surge After U.S. AI Model Launch"... Appears to Circumvent Export Restrictions

It has been revealed that stablecoin transactions originating from cryptocurrency wallets linked to China surged immediately after the release of a major U.S. artificial intelligence (AI) model. Analy…
2026-11-23 07:28:14

Corporation

"Beyond the Domestic Home Shopping Market to Vietnam": GS Retail Sees Success in Export Consultations with Small and Medium-Sized Enterprises

GS Retail(007070)has supported domestic small and medium-sized partner companies in Vietnam in expanding their overseas sales channels, resulting in export consultation deals totaling approximately $1…
2026-11-22 18:23:06

IT·Science

BioSite, Which Has Partnered with Samsung Bioepis, Also Receives Interest from Japanese Big Pharma

Astellas Pharma, a major Japanese pharmaceutical company, has also expressed interest in the new drug development technology from BioSite that Samsung Bioepis had previously highlighted. BioSite, a ne…
2026-11-23 07:31:02